Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Jeong, Hyun Ja ^a   Nam, Sun Young ^b   Oh, Hyun A ^b   Han, Na Ra ^b   Kim, Young Sick ^b   Moon, Phil Dong ^b   Shin, Seung Youp ^c   Kim, Min Ho ^d   Kim, Hyung Min ^b  

^a Hoseo University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 32; MESSENGER RNA; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KOREAN MEDICINE; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; UPREGULATION; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CASPASE 1; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; CHONDROITIN SULFATES; CYTOKINES; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INTERLEUKINS; MACROPHAGES; MEDICINE, KOREAN TRADITIONAL; MONOCYTES; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84870053476     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4104     Document Type: Article

References (40)

1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996, 85:307-310. 10.1016/S0092-8674(00)81109-5, 8616886.
2. Kinne RW, Brauer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000, 2:189-202. 10.1186/ar86, 130001, 11094428.
3. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:669-675.
4. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis Rheum 2002, 46:298-308. 10.1002/art.502, 11840432.
5. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 2005, 4:273-279. 10.2174/1568010054022114, 16101533.
6. Martinez-Gamboa L, Brezinschek HP, Burmester GR, Dorner T. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmun Rev 2006, 5:437-442. 10.1016/j.autrev.2006.02.004, 16920569.
7. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNF alpha. Immunity 2005, 22:131-142.
8. Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102:16309-16314. 10.1073/pnas.0508237102, 1283464, 16260731.
9. Meyer N, Zimmermann M, Bürgler S, Bassin C, Woehrl S, Moritz K, Rhyner C, Indermitte P, Schmid-Grendelmeier P, Akdis M, Menz G, Akdis CA. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010, 125:858-865. 10.1016/j.jaci.2010.01.016, 20227751.
10. Kempuraj D, Conti P, Vasiadi M, Alysandratos KD, Tagen M, Kalogeromitros D, Kourelis T, Gregoriou S, Makris M, Stavrianeas NG, Theoharides TC. IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol 2010, 20:865-867. 3273318, 21047723.
11. Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS, Kim HM. IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol 2011, 224:553-563. 10.1002/path.2899, 21598250.
12. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103:3298-3303. 10.1073/pnas.0511233103, 1413916, 16492735.
13. Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-18/interferon-gamma-dependent mechanism. PLoS Med 2006, 3:e277. 10.1371/journal.pmed.0030277, 1539091, 16903774.
14. Lee S, Kim JH, Kim H, Kang JW, Kim SH, Yang Y, Kim J, Park J, Park S, Hong J, Yoon DY. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene. Immunology 2011, 132:410-420. 10.1111/j.1365-2567.2010.03377.x, 3044907, 21208204.
15. Hartgring SA, Willis CR, Dean CE, Broere F, van Eden W, Bijlsma JW, Lafeber FP, van Roon JA. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis Rheum 2011, 63:1878-1887. 10.1002/art.30336, 21391201.
16. Bunyavanich S, Melen E, Wilk JB, Granada M, Soto-Quiros ME, Avila L, Lasky-Su J, Hunninghake GM, Wickman M, Pershagen G, O'Connor GT, Weiss ST, Celedón JC. Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in children with asthma. Clin Mol Allergy 2011, 9:e1.
17. Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010, 11:289-293. 10.1038/ni.1852, 2924817, 20300138.
18. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007, 204:253-258. 10.1084/jem.20062211, 2118732, 17242164.
19. Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W, Largaespada DA, Copeland NG, Jenkins NA, Farr AG, Ziegler SF, Morrissey PJ, Paxton R, Sims JE. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000, 192:659-670. 10.1084/jem.192.5.659, 2193276, 10974032.
20. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, Zurawski SM, Johnston J, Liu YJ, Spits H, de Waal Malefyt R, Kastelein RA, Bazan JF. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001, 167:336-343.
21. Rochman I, Watanabe N, Arima K, Liu YJ, Leonard WJ. Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4 T cells. J Immunol 2007, 178:6720-6724.
22. Nagata Y, Kamijuku H, Taniguchi M, Ziegler S, Seino K. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int Arch Allergy Immunol 2007, 144:305-314. 10.1159/000106319, 17652941.
23. Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, Liu YJ. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4 T cell homeostatic expansion. Nat Immunol 2004, 5:426-434. 10.1038/ni1048, 14991051.
24. Liu YJ. TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol 2009, 101:1-25.
25. Zhang K, Shan L, Rahman MS, Unruh H, Halayko AJ, Gounni AS. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2007, 293:L375-382. 10.1152/ajplung.00045.2007, 17513456.
26. Moon PD, Kim HM. Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells. Cytokine 2011, 54:239-243. 10.1016/j.cyto.2011.03.007, 21463955.
27. Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY, Dinarello CA, Kim SH. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA 2008, 105:3515-3520. 10.1073/pnas.0712381105, 2265135, 18296636.
28. He R, Geha RS. Thymic stromal lymphopoietin. Ann NY Acad Sci 2010, 1183:13-24. 10.1111/j.1749-6632.2009.05128.x, 2895428, 20146705.
29. Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA, Chan ED. IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J Immunol 2010, 184:3830-3840. 10.4049/jimmunol.0901913, 20190143.
30. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008, 181:557-565.
31. Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol 2010, 185:5056-5065. 10.4049/jimmunol.0902667, 20889550.
32. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007, 149:480-486. 10.1111/j.1365-2249.2007.03439.x, 2219317, 17590175.
33. Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello CA, Saetta M. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178:894-901. 10.1164/rccm.200804-646OC, 18703789.
34. Kobayashi K, Inohara N, Hernandez LD, Galán JE, Núñez G, Janeway CA, Medzhitov R, Flavell RA. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416:194-199. 10.1038/416194a, 11894098.
35. Seljelid R, Eskeland T. The biology of macrophages: I General principles and properties. Eur J Haematol 1993, 51:267-275.
36. Kusmartsev S, Gabrilovich DI. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Rev 2006, 25:323-331. 10.1007/s10555-006-9002-6, 1693571, 16983515.
37. Moeenrezakhanlou A, Shephard L, Lam L, Reiner NE. Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J Leukoc Biol 2008, 84:519-528. 10.1189/jlb.1207833, 18495781.
38. Zhang Y, Zhou B. Functions of thymic stromal lymphopoietin in immunity and disease. Immunol Res 2012, 52:211-223. 10.1007/s12026-012-8264-z, 22274860.
39. David-Raoudi M, Deschrevel B, Leclercq S, Galéra P, Boumediene K, Pujol JP. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. Arthritis Rheum 2009, 60:760-770. 10.1002/art.24302, 19248106.
40. Vallières M, du Souich P. Modulation of inflammation by chondroitin sulfate. Osteoarthritis Cartilage 2010, 18:S1-6.